What one share of MiniMed Group holds
We are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes.
MiniMed Group’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-07-31; the balance sheet is as of 2026-07-31.
| Sales | $12.20 |
|---|---|
| Profit | −$1.19 |
| Capex (buildings and equipment) | $0.80 |
| Free cash flow | −$1.20 |
| Cash and investments | $0.74 |
| Book value | $12.87 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | $9.77 | −$0.44 | $0.59 | −$0.42 | — | $13.64 |
| 2025 | $10.74 | −$0.84 | $0.76 | −$0.21 | — | $13.17 |
| 2026 | $12.09 | −$1.30 | $0.87 | −$1.64 | — | $12.86 |
Common questions about MiniMed Group
How much does one share of MiniMed Group earn?
Over the last 12 months, MiniMed Group lost $1.19 for each share on $12.20 of sales.
Does MiniMed Group pay a dividend?
MiniMed Group didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is MiniMed Group’s book value per share?
MiniMed Group’s book value is $12.87 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of July 31, 2026.
How much cash and debt does each share of MiniMed Group have?
Each share of MiniMed Group has $0.74 of cash and investments, as of July 31, 2026.
What is MiniMed Group’s free cash flow per share?
−$1.20 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.